A multi-center clinical trial conducted in 2011 validated that<unk>  is safe and effective and provides substantial benefit for individuals with single-sided deafness (SSD). Trial participants wore<unk>  for 30 days, using the device an average of 8.2 hours per day. Based on the clinical trial results,<unk>  improves the ability of individuals with SSD to understand speech in an environment with background noise by an average of 25%. One-third of the trial participants found that the<unk>  improved their<unk>  ability by more than 30%. The results of this extensive clinical trial showed<unk>  to be as effective as surgically implanted bone conduction<unk> s in improving the ability to understand speech in an environment with background noise. In 2013, another multi-center clinical study confirmed previous findings that<unk>  is safe, effective, and provides significant benefit for patients. Study participants wore<unk>  for 6 month. Benefit was determined through a standard audiological questionnaire called the Abbreviated Profile of<unk>  Aid Benefit (APHAB), and a patient survey. Results from the APHAB questionnaire showed patients had significant improvement in Ease of Communication, Reverberation, Background Noise, and Global Benefit. Additionally, the patient survey showed strong satisfaction with the device: 100% would recommend<unk>  to a friend or family member with similar<unk>  loss.
SoundBite Hearing System
Computational audiology
Glasgow Committee on Anæsthetics
Brigance Inventory of Early Development 
Audio power amplifier
Schimmelbusch mask
Piphilology
Phonological Awareness for Literacy